The present advances in biology are related to progress in genomics, proteomics, and other
“-omics”, including glycomics, working with a large amount of data regarding human and …

Microfluidic systems enable rapid diagnosis, screening and monitoring of diseases and
health conditions using small amounts of biological samples and reagents. Despite these …

The need to calibrate to correct for sensor-to-sensor fabrication variation and sensor drift has
proven a significant hurdle in the widespread use of biosensors. To maintain clinically …

Here, we report a strategy for the design of an inexpensive paper analytical device (PAD) for
quantitative detection of oligonucleotides and proteins. Detection is based on the principle of …

There is a need for biosensing systems that can be operated at the point‐of‐care (POC) for
disease screening and diagnostics and health monitoring. In spite of this, simple to operate …

For an assay to be most effective in point-of-care clinical analysis, it needs to be economical,
simple, generalizable, and free from tedious workflows. While electrochemistry-based DNA …

The ability to measure the levels of diagnostically relevant proteins, such as antibodies,
directly at the point of care could significantly impact healthcare. Thus motivated, we explore …

While the exploration into biomolecules for diagnostic and prognostic devices continues to
develop, many molecules continue to be examined for individual diseases or treatments …

Here we demonstrate a new class of reagentless, single-step sensors for the detection of
proteins and peptides that is the electrochemical analog of fluorescence polarization …

Specific and sensitive electroanalysis of blood‐circulating protein cancer biomarkers is often
complicated by interference from serum proteins nonspecifically adsorbing at the biosensing …